Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy

BACKGROUND/OBJECTIVE: Reducing severity of Cushing’s syndrome caused by an adrenal adenoma (adrenal Cushing’s syndrome [ACS]) might decrease morbidity and mortality risk in adrenalectomy. We used off-label osilodrostat, approved in the United States for pituitary Cushing’s disease, to reduce cortiso...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Risha B., Ben-Shlomo, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701912/
https://www.ncbi.nlm.nih.gov/pubmed/36447826
http://dx.doi.org/10.1016/j.aace.2022.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701912/
https://www.ncbi.nlm.nih.gov/pubmed/36447826
http://dx.doi.org/10.1016/j.aace.2022.10.001

Ejemplares similares